| They say clinically effective treatments will now struggle to gain approval Related items from OnMedica Cancer Drugs Fund decision NICE’s cost-effectiveness system is harming patients, claim experts UK pays less than neighbours for cancer drugs Cancer Drugs Fund axes 25 treatments from list The medicine price debate |
No comments:
Post a Comment